Ariana Thacker is the founder and CEO of MoldCo, and a chemical engineer turned venture capitalist with a passion for tackling overlooked challenges. After successfully founding Conscience VC, an early-stage firm investing in science-driven startups, Ariana’s own experience with Mold Toxicity led her to create MoldCo, the first and only platform focused exclusively on environmental and Mold Toxicity diagnosis and treatment at scale. Today, the company is rapidly scaling to meet growing demand, offering advanced lab testing in 46 states and counting.
Ariana is on a mission to bridge gaps in healthcare and empower patients through innovation and empathy, drawing on her engineering expertise and experience scaling impactful companies. She is a domain expert in Mold Toxicity with insight into the pathophysiology, biomarkers, research-backed treatments, and emerging science.
Symptoms often get labeled as anxiety, chronic fatigue, early neurodegeneration, IBS, or fibromyalgia. How to prevent the root cause — mold exposure — from going unrecognized.